BUILDING A LEADING ONCOLOGY FRANCHISE

DIFFERENTIATED CANDIDATES ADDRESSING CLEAR NEEDS

STRONG FINANCIALS, OPTIMALLY BUILDING VALUE

View our 2018 annual report.

Latest News

MEI Pharma Reports First Quarter Fiscal Year 2019 Results and Operational Highlights
MEI Pharma To Present at Stifel 2018 Healthcare Conference
MEI Pharma and Kyowa Hakko Kirin Announce License Agreement to Develop and Commercialize ME-401 in Japan
MEI Pharma to Present Clinical Data from Three Oncology Programs at the 2018 American Society of Hematology (ASH) Annual Meeting